Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome.
about
Predicting and managing sepsis in burn patients: current perspectives.Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue.Irritable Bowel Syndrome and Depression: A Shared PathogenesisSqualene Stimulates a Key Innate Immune Cell to Foster Wound Healing and Tissue Repair
P2860
Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Interleukin-10: A Compelling T ...... With Irritable Bowel Syndrome.
@en
type
label
Interleukin-10: A Compelling T ...... With Irritable Bowel Syndrome.
@en
prefLabel
Interleukin-10: A Compelling T ...... With Irritable Bowel Syndrome.
@en
P2093
P1476
Interleukin-10: A Compelling T ...... With Irritable Bowel Syndrome.
@en
P2093
Awanish Kumar
Prabhat Ranjan
Ratnakar Shukla
Sunil Kumar
P304
P356
10.1016/J.CLINTHERA.2017.01.030
P577
2017-02-23T00:00:00Z